Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo
Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo
复制标题
染色质结构(而非 DNA 序列特异性)是拓扑异构酶 II 体内作用位点的主要决定因素
DOI:
--
复制
发表时间:
1991
影响因子:
5.3
通讯作者:
Paul Schedl
中科院分区:
文献类型:
--
作者:
Andor Udvardy;Paul Schedl
In the studies reported here we have used topoisomerase II as a model system for analyzing the factors that determine the sites of action for DNA-binding proteins in vivo. To localize topoisomerase II sites in vivo we used an inhibitor of the purified enzyme, the antitumor drug VM-26. This drug stabilizes an intermediate in the catalytic cycle, the cleavable complex, and substantially stimulates DNA cleavage by topoisomerase II. We show that lysis of VM-26 treated tissue culture cells with sodium dodecyl sulfate induces highly specific double-strand breaks in genomic DNA, and we present evidence indicating that these double-strand breaks are generated by topoisomerase II. Using indirect end labeling to map the cleavage products, we have examined the in vivo sites of action of topoisomerase II in the 87A7 heat shock locus, the histone repeat, and a tRNA gene cluster at 90BC. Our analysis reveals that chromatin structure, not sequence specificity, is the primary determinant in topoisomerase II site selection in vivo. We suggest that chromatin organization may provide a general mechanism for generating specificity in a wide range of DNA-protein interactions in vivo.
DOI:
10.1016/s0021-9258(18)90729-5
发表时间:
1984-11
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
G. L. Chen;L. Yang;T. Rowe;B. Halligan;K. M. Tewey;L. Liu
通讯作者:
G. L. Chen;L. Yang;T. Rowe;B. Halligan;K. M. Tewey;L. Liu
影响因子:
5.6
作者:
M. Sander;T. Hsieh;A. Udvardy;P. Schedl
通讯作者:
M. Sander;T. Hsieh;A. Udvardy;P. Schedl
DOI:
--
发表时间:
1989
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Lee,MP;Sander,M;Hsieh,T
通讯作者:
Hsieh,T